300841.SZ · 康华生物
China A-shares · RS rating 68 · As of 2026-10-14
| Price | 51.24 CNY |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 79 / 82 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 16 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +112.2% |
| Distance from 52-week high | +39.1% |
| Market cap (USD) | $1.1B |